SCHEMBL5429002

SCHEMBL5429002

O=C(O)N1CCC(n2ccccc2=O)CC1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 1/20 0.47
L3MBTL1 Q9Y468 5/20 0.43
L3MBTL3 Q96JM7 3/20 0.43
GAA P10253 1/20 0.42
TP53BP1 Q12888 2/20 0.41
ACHE P22303 1/20 0.39
ALOX15 P16050 1/20 0.39
KDM4E B2RXH2 5/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
MBTD1 Q05BQ5 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
THRB P10828 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28541089 0.90 KDM5A (0.54) KDM5AL3MBTL1L3MBTL3GAATP53BP1
SCHEMBL27426 0.82 KDM5A (0.40) KDM5AKMT2A
SCHEMBL4214094 0.80 L3MBTL1 (0.38) L3MBTL1L3MBTL3GAATP53BP1ACHE
SCHEMBL16669802 0.78 L3MBTL3 (0.40) KDM5AL3MBTL1L3MBTL3MBTD1ALDH1A1
SCHEMBL21245631 0.78 SMN1; SMN2 (0.41) KDM5AL3MBTL1L3MBTL3TP53BP1ALOX15
SCHEMBL15797759 0.78 ALDH1A1 (0.40) KDM5AKDM4ECYP2C9CYP2C19KMT2A
SCHEMBL30558157 0.78 KDM5A (0.39) KDM5AL3MBTL1L3MBTL3KDM4ECYP2C9
SCHEMBL8337639 0.77 CHRM2 (0.44) KDM5AL3MBTL1ACHEALOX15
SCHEMBL7190295 0.77 ALDH1A1 (0.42) KDM4ECYP2C9CYP2C19KMT2ASMN1; SMN2
Hydrochloric Acid SCHEMBL30612389 0.77 KDM5A (0.38) KDM5AL3MBTL1L3MBTL3KDM4ECYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070129361-A1 LACTAM-CONTAINING DIAMINOALKYL, Beta-AMINOACIDS, Alpha-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS QIAO JENNIFER X 2007-06-07 US claimed
US-20070129361-A1 LACTAM-CONTAINING DIAMINOALKYL, Beta-AMINOACIDS, Alpha-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS QIAO JENNIFER X 2007-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129361-A1 LACTAM-CONTAINING DIAMINOALKYL, Beta-AMINOACIDS, Alpha-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS PEPD, XPNPEP1, METAP1 KDM5A 3665/4885L3MBTL1 1475/4885L3MBTL3 3919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.